Navigation Links
ReSearch Pharmaceutical Services anuncia a Marc Wolff como responsable financiero
Date:7/25/2013

FORT WASHINGTON, Pennsylvania, 25 de julio de 2013 /PRNewswire/ -- ReSearch Pharmaceutical Services, Inc. (RPS), una CRO de próxima generación que proporciona soluciones de desarrollo clínico global en fase 1-4 para las industrias de dispositivos médicos y biofarmacéutica, anunció hoy que Marc Wolff se une a la organización en el cargo de responsable financiero.

En su cargo, Marc dirigirá todas las finanzas, impuestos y aspectos de tesorería de los negocios, incluyendo las prácticas de contabilidad, presupuesto, planificación financiera, finanzas, interfaz con la comunidad financiera, análisis financiero, adquisiciones y empresas y control del rendimiento financiero, de impuestos y tesorería. Se une a la compañía procedente de Catalent Pharma Solutions, donde trabajó en un doble cargo como responsable de finanzas mundial de Softgel Technologies además de ser vicepresidente y responsable general de Softgel Businesses en Australia y Japón.

Wolff cuenta con más de 15 años de experiencia como responsable financiero en corporaciones públicas y privadas, disponiendo entre 50 millones de dólares y 1.500 millones de dólares en ingresos, con un record establecido de éxito en las principales organizaciones globales de finanzas y un valor empresariales creciente destacado. 

Acerca de RPS
ReSearch Pharmaceutical Services (RPS), el principal proveedor mundial de mercado de innovadoras soluciones de desarrollo clínico de externalización, ofrece soluciones de desarrollo clínico de fase I-IV globales completas para las industrias farmacéutica, biotecnológica, de dispositivos médicos y diagnóstico, personalizadas por tipo (grandes, tamaño medio y pequeño). Construida de forma orgánica, RPS es la organización de investigación clínica (CRO) de crecimiento más rápido dentro de las 10 primeras, y cuenta con más de 5.000 empleados y realiza operaciones en más de 64 países, disponiendo de estructuras internas propias. Estas estructuras han proporcionado a RPS y sus socios una flexibilidad de desarrollo y crecimiento superior.

Si desea más información sobre RPS, visite www.rpsweb.com.


'/>"/>
SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Water Treatment Industry Reports: Equipment Research for US & Global Wastewater Treatment Markets
2. Organovo and Methuselah Foundation Announce Funding of Bioprinting Research at Research Institutions
3. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
4. BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
5. Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) Is Expected to Reach USD 5.0 Billion Globally in 2018: Transparency Market Research
6. ResearchMoz.us: Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
7. ResearchDx, the leading Contract Diagnostics Organization, completes their expansion into a new facility
8. Heptares Achieves First Research Milestone in Research Collaboration with Cubist
9. Leadership Through Research Collaboration Is Reflected In Articles Published In Alzheimers Association Journal
10. Todays Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn
11. Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016  Marking its one year ... and ovarian cancer risk test, Color Genomics ... genes that highly impact the most common hereditary ... the Color Test analyzes hereditary cancer risks for ... uterine cancers. The Color Test is physician ordered ...
(Date:4/28/2016)... Dr. Vivek Ahuja , ... phen Schmidt Join the Growing ... solutions for life sciences, today announced key new leaders have joined ... to a growing business.  This will bolster the company,s safety business ... joined ArisGlobal in the position of Vice President - Safety. George ...
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... billing and coding services, and Deyta Analytics, recently announced the recipients of the ... level of quality as measured from the caregiver’s point of view. The official ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intellitec Solutions ... use of Microsoft Dynamics GP for one their long-term care clients. Working together ... Dynamics GP with key clinical management systems, and delivered a fully integrated accounting ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Society ... year, reproductive endocrinologists are required to report in vitro fertilization (IVF) ... dedicated to the practice of assisted reproductive technologies in the United States. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... BC and AD, saying it is time to set the record straight. Traditionally, BC ... this simply cannot possibly be true and offers explanation. , “To start with, the ...
Breaking Medicine News(10 mins):